5ml tirzepatide MOUNJARO® Prefilled Pen (Tirzepatide)* Inj 2.5mg/.5ml while decreasing the production of glucagon Tirzepatide Weight Loss Injections •

Long-term GLP-1 users typically report energy levels that match or exceed their pre-treatment baseline by month 34, especially as they lose weight and cardiovascular fitness improves

Regular weight checks and nutritional assessments are advisable, particularly in the first few months of combined treatment

Which foods should I avoid when taking GLP-1 medication

Safety Profile and Side Effects of GLP-1 Drugs Whilst GLP-1 receptor agonists are generally well-tolerated, healthcare professionals and patients must be aware of their safety profile to ensure appropriate use and monitoring

Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals